Form C-AR — Berkshire Biomedical Corp
0001665160-25-000999 · filed May 6, 2025
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 2048576
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 5950 BERKSHIRE LN., SUITE 375
DALLAS, TX 75225 - Phone
- —
Most recent fiscal year financials
- Total assets
- $173,383
- Cash
- —
- Short-term debt
- —
- Long-term debt
- $9,535,643
- Revenues
- $221,860
- COGS
- —
- Taxes paid
- —
- Net income
- $-4,258,282
Likely investment adviser (not guaranteed)
-
BERKSHIRE CAPITAL HOLDINGS INC
medium CRD 801-53149
-
BERKSHIRE PARTNERS LLC
medium CRD 801-73336
View the original filing on SEC EDGAR ↗